Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

TAP compound huMy9-6-DM4 enters clinical testing

March 22, 2005

Phase II study of GCAN-101 set to begin in Israel

March 18, 2005

Update on the safety and immunogenicity of rsPSMA vaccine in prostate cancer

March 16, 2005

Antitumor effects found for TG-4010 in prostate cancer patients

March 16, 2005

PSA-TRICOM vaccines show promise in the treatment of prostate cancer

March 15, 2005

Ceplene designated orphan drug in Europe for AML

March 14, 2005

Complete and partial responses in phase I/II study of MDX-010 for metastatic melanoma

March 14, 2005

Clinical evidence supports the use of TroVax in metastatic colorectal cancer

March 10, 2005

Pharmexa and BN ImmunoTherapeutics enter license agreement

March 9, 2005

First phase I data on the effects of GPI-0100 in prostate cancer

Feb. 28, 2005

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...